BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 19787646)

  • 1. Cytology of systemic mastocytosis.
    Bain BJ; Marks AJ
    Am J Hematol; 2009 Dec; 84(12):842. PubMed ID: 19787646
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.
    Ustun C; Savage NM; Gotlib J; Bhalla K; Manaloor E; George TI
    Am J Hematol; 2012 Feb; 87(2):191-3. PubMed ID: 22081475
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic mastocytosis.
    George TI; Horny HP
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):1067-83, vii. PubMed ID: 22054735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
    Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
    Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease.
    Zhao W; Bueso-Ramos CE; Verstovsek S; Barkoh BA; Khitamy AA; Jones D
    Leukemia; 2007 Jul; 21(7):1574-6. PubMed ID: 17410189
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
    Kim Y; Weiss LM; Chen YY; Pullarkat V
    Leuk Res; 2007 Dec; 31(12):1749-54. PubMed ID: 17544505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
    Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
    Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonality and molecular pathogenesis of mastocytosis.
    Akin C
    Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
    Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
    Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mastocytosis: current classification and novel therapeutic options.
    Barbie DA; Deangelo DJ
    Clin Adv Hematol Oncol; 2006 Oct; 4(10):768-75. PubMed ID: 17099633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
    McClintock-Treep SA; Horny HP; Sotlar K; Foucar MK; Reichard KK
    J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia.
    Caocci G; Greco M; Frau V; Asproni R; Piras G; Palmas A; Casula P; La Nasa G
    Ann Hematol; 2020 Feb; 99(2):363-365. PubMed ID: 31807857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations in cutan mastocytosis].
    Mihalik N; Hidvégi B; Hársing J; Várkonyi J; Csomor J; Kovalszky I; Marschalkó M; Kárpáti S
    Orv Hetil; 2013 Sep; 154(37):1469-75. PubMed ID: 24016753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
    Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
    Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
    Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin lesions and mast cells.
    Blood; 2008 Jul; 112(1):28. PubMed ID: 18584778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.